Tomoregulin-2 is a transmembrane protein that contains EGF-like and follistatin-like domains. These domains are involved in various cellular processes, including cell signaling and regulation of cell growth. The protein has been shown to function as both an oncogene and a tumor suppressor, depending on the cellular context . This dual role suggests that Tomoregulin-2 may play a complex role in cancer biology, particularly in prostate cancer cell invasion .
The Mouse Anti Human Tomoregulin-2 Antibody is a monoclonal antibody derived from mouse and is used to detect human TMEFF2 in various applications, including Western blotting and immunohistochemistry . This antibody is highly specific and can be used to study the expression and localization of TMEFF2 in human tissues.
Research on Tomoregulin-2 has significant implications for understanding cancer biology, particularly in the context of prostate cancer. The ability of Tomoregulin-2 to act as both an oncogene and a tumor suppressor highlights its potential as a therapeutic target. Studies using the Mouse Anti Human Tomoregulin-2 Antibody can provide insights into the protein’s role in cancer progression and may lead to the development of new diagnostic and therapeutic strategies.